- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Relief Therapeutics Holding SA (RLFB)
Relief Therapeutics Holding SA stock price live, this page displays SIX RLFB stock exchange data. View the RLFB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Relief Therapeutics Holding SA real time stock price chart below.
What Is the Relief Therapeutics Holding SA Stock Price Today?
The Relief Therapeutics Holding SA stock price today is 2.1800.
What Is the Stock Symbol for Relief Therapeutics Holding SA?
The stock symbol for Relief Therapeutics Holding SA is "RLFB."
What Stock Exchange Does Relief Therapeutics Holding SA Trade On?
Relief Therapeutics Holding SA is listed and trades on the Switzerland stock exchange.
Is Relief Therapeutics Holding SA a Good Stock to Buy?
Determining whether Relief Therapeutics Holding SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RLFB quote. (ISIN: CH1251125998)
What Is the Relief Therapeutics Holding SA Stock Price Today?
The Relief Therapeutics Holding SA stock price today is 2.1800.
What Is the Stock Symbol for Relief Therapeutics Holding SA?
The stock symbol for Relief Therapeutics Holding SA is "RLFB."
What Stock Exchange Does Relief Therapeutics Holding SA Trade On?
Relief Therapeutics Holding SA is listed and trades on the Switzerland stock exchange.
Is Relief Therapeutics Holding SA a Good Stock to Buy?
Determining whether Relief Therapeutics Holding SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RLFB quote. (ISIN: CH1251125998)
2.1800
+0.0750(+3.56%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.1000
2.2650
52 wk Range
1.0550
7.6000
RLFB Scorecard
Full Analysis
High shareholder yield
RLFB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.10002.2650
52 wk Range
1.05507.6000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
RLFB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Relief Therapeutics Holding SA Company Profile
Relief Therapeutics Holding SA, a biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for nausea and vomiting associated with radiotherapy-induced, chemotherapy, and postoperative sequels; ACER-001, a sodium phenylbutyrate for the treatment of urea cycle disorders; and PKU GOLIKE for the dietary management of phenylketonuria. It also develops RLF-100, a synthetic form of vasoactive intestinal peptide for the treatment of acute respiratory distress syndrome and certain chronic lung diseases, including sarcoidosis, berylliosis, and checkpoint inhibitor-induced pneumonitis. In addition, the company develops RLF-TD011, a hypochlorous acid solution for epidermolysis bullosa. Further, it is developing RLF-OD32, a next-generation liquid sapropterin formulation for phenylketonuria. Relief Therapeutics Holding SA was founded in 2013 and is based in Geneva, Switzerland.
Compare RLFB to Peers and Sector
Metrics to compare | RLFB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRLFBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −3.0x | −0.5x | |
PEG Ratio | −0.02 | −0.06 | 0.00 | |
Price/Book | - | 1.5x | 2.6x | |
Price / LTM Sales | 3.1x | 4.6x | 2.9x | |
Upside (Analyst Target) | - | 72.6% | 50.4% | |
Fair Value Upside | Unlock | 20.8% | 9.1% | Unlock |
Earnings
Latest Release
Apr 10, 2025
EPS / Forecast
-0.50 / --
Revenue / Forecast
1.38M / --
People Also Watch
FAQ
What Is the Relief Therapeutics (RLFB) Stock Price Today?
The Relief Therapeutics stock price today is 2.18
What Stock Exchange Does Relief Therapeutics Trade On?
Relief Therapeutics is listed and trades on the Switzerland Stock Exchange stock exchange.
What Is the Stock Symbol for Relief Therapeutics?
The stock symbol for Relief Therapeutics is "RLFB."
What Is the Relief Therapeutics Market Cap?
As of today, Relief Therapeutics market cap is 26.66M.
What Is Relief Therapeutics's Earnings Per Share (TTM)?
The Relief Therapeutics EPS (TTM) is -1.37.
From a Technical Analysis Perspective, Is RLFB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.